Issued Patents All Time
Showing 1–12 of 12 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12385070 | Homology directed repair compositions for the treatment of hemoglobinopathies | Andrew M. Scharenberg, Kyle Jacoby, Hans-Peter Kiem, Christopher Lux, Sowmya Pattabhi +1 more | 2025-08-12 |
| 12110499 | Homology directed repair compositions for the treatment of hemoglobinopathies | Andrew M. Scharenberg, Kyle Jacoby, Hans-Peter Kiem, Christopher Lux, Sowmya Pattabhi +1 more | 2024-10-08 |
| 11987804 | Rapamycin resistant cells | Andrew M. Scharenberg, Karen Sommer, Samuel West, Yuchi Chiang Honaker, Ryo Takeuchi | 2024-05-21 |
| 11939594 | Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins | Richard James, Shaun W. Jackson, Iram Khan, King Wai Hung, Andrew M. Scharenberg | 2024-03-26 |
| 11713459 | Expression of FOXP3 in edited CD34+ cells | Iram Khan, Yuchi Chiang Honaker, Swati Singh, Karen Sommer, Andrew M. Scharenberg | 2023-08-01 |
| 11712454 | Method for treating autoimmune disease using CD4 T-cells with engineered stabilization of expression of endogenous FOXP3 gene | Andrew M. Scharenberg, Troy Torgerson | 2023-08-01 |
| 11643671 | Therapeutic genome editing in Wiskott-Aldrich syndrome and X-linked thrombocytopenia | Iram Khan | 2023-05-09 |
| 10745690 | Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption | Andrew M. Scharenberg, Michael T. Certo, Kamila Sabina Gwiazda | 2020-08-18 |
| 10563226 | Enhancing endonuclease based gene editing in primary cells | Andrew M. Scharenberg, Michael C. Jensen, Kamila Sabina Gwiazda, Alexandra E. Grier | 2020-02-18 |
| 10494422 | CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies | Thor Wagner, Andrew M. Scharenberg, Blythe SATHER, Jaya Sahni | 2019-12-03 |
| 6994975 | Expression and purification of ATM protein using vaccinia virus | Richard A. Gatti, Helen Chun | 2006-02-07 |
| 5550054 | Hematopoietic restricted tyrosine kinase (BPK) | Owen N. Witte, Satoshi Tsukada, Douglas Saffran | 1996-08-27 |